Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Estrogen metabolism WP697,0.0040763704113998605,13.022013422818793,71.65425771225352,"['SULT1A1', 'STS', 'ARSE']",0.9954001499655907,0,0,3
2,Purine metabolism WP4792,0.010874878004844062,8.13724832214765,36.79094018807394,"['ADSL', 'ATIC', 'HPRT1']",0.9954001499655907,0,0,3
3,Glycosylation and related congenital defects WP4521,0.02285901701300499,4.135432667690732,15.625358582098956,"['ALG8', 'ALG6', 'MAGT1', 'ALG11']",0.9954001499655907,0,0,4
4,NOTCH1 regulation of endothelial cell calcification WP3413,0.03132702676476232,5.005988642230253,17.337110704922548,"['DLL4', 'CALU', 'DLL1']",0.9954001499655907,0,0,3
5,Hepatitis C and Hepatocellular Carcinoma WP3646,0.033514450343843094,3.0166741438612235,10.243957439386548,"['CASP9', 'RRM2', 'PODXL', 'MYOF', 'PTGS2']",0.9954001499655907,0,0,5
6,Mitochondrial CII Assembly WP4920,0.045761882618600175,7.224307417336908,22.281958759092756,"['SDHAF4', 'SDHB']",0.9954001499655907,0,0,2
7,Nucleotide metabolism WP404,0.04917684588027559,4.066610738255034,12.249983197382102,"['ADSL', 'RRM2', 'HPRT1']",0.9954001499655907,0,0,3
8,One-carbon metabolism and related pathways WP3940,0.051319292260923854,2.647966385451203,7.863635402797061,"['DMGDH', 'BHMT', 'AHCYL1', 'BHMT2', 'GPX7']",0.9954001499655907,0,0,5
9,Purine metabolism and related disorders WP4224,0.05601664525041608,3.827161468614291,11.030286546446698,"['ADSL', 'ATIC', 'HPRT1']",0.9954001499655907,0,0,3
10,Non-homologous end joining WP438,0.06938978928390105,5.4175603217158175,14.454135185560851,"['XRCC4', 'XRCC5']",0.9954001499655907,0,0,2
11,Oxidative Damage WP3941,0.07913569211545106,2.629683936135549,6.670433336891852,"['CASP9', 'TRAF6', 'TRAF2', 'TRAF1']",0.9954001499655907,0,0,4
12,Farnesoid X receptor pathway WP2879,0.08239311806048356,4.815311289842121,12.020237007121821,"['ABCB4', 'ABCB11']",0.9954001499655907,0,0,2
13,SCFA and skeletal muscle substrate metabolism WP4030,0.0864539517314115,21.650602409638555,53.00377845811478,['PYY'],0.9954001499655907,0,0,1
14,Arylamine metabolism WP694,0.0864539517314115,21.650602409638555,53.00377845811478,['SULT1A1'],0.9954001499655907,0,0,1
15,16p11.2 distal deletion syndrome WP4950,0.10544511871579225,2.8277210388094542,6.3611413261909515,"['TRAF2', 'TRAF1', 'SH2B1']",0.9954001499655907,0,0,3
16,SARS-CoV-2 mitochondrial interactions WP5038,0.10544511871579225,2.8277210388094542,6.3611413261909515,"['TRAF6', 'ACAD9', 'NDUFAF1']",0.9954001499655907,0,0,3
17,3q29 copy number variation syndrome WP4906,0.10653039999435636,2.08639610725748,4.67211873047695,"['TM4SF19', 'DYNLT1', 'PIGZ', 'DYNLRB2', 'MELTF']",0.9954001499655907,0,0,5
18,Small cell lung cancer WP4658,0.107712319518859,1.8094916779127306,4.032074588647849,"['CASP9', 'LAMA1', 'TRAF6', 'TRAF2', 'E2F3', 'TRAF1', 'PTGS2']",0.9954001499655907,0,0,7
19,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.11032343976952612,3.9393126980258346,8.683580085807689,"['TNC', 'VHL']",0.9954001499655907,0,0,2
20,Eukaryotic Transcription Initiation WP405,0.11333721125569783,2.282965478211658,4.970901028635033,"['CDK7', 'TAF12', 'ERCC3', 'POLR2F']",0.9954001499655907,0,0,4
21,One-carbon metabolism WP241,0.12471454539172706,2.601181208053691,5.414951207686336,"['BHMT', 'ATIC', 'AMT']",0.9954001499655907,0,0,3
22,Nucleotide Excision Repair WP4753,0.12857012236633109,2.168548387096774,4.448301722666409,"['RFC3', 'CDK7', 'ERCC3', 'ERCC8']",0.9954001499655907,0,0,4
23,Trans-sulfuration and one-carbon metabolism WP2525,0.13479083444246304,2.5009808982963344,5.012043442083517,"['BHMT', 'AHCYL1', 'AMT']",0.9954001499655907,0,0,3
24,MAPK Signaling Pathway WP382,0.1415473950962996,1.4091482490665053,2.7550548692729886,"['DUSP1', 'HSPA6', 'TRAF2', 'FOS', 'FGF1', 'RASGRP1', 'PAK1', 'TRAF6', 'RAC2', 'MAPT', 'PTPN7', 'HSPA1B', 'HSPA1A', 'CACNG5']",0.9954001499655907,0,0,14
25,Zinc homeostasis WP3529,0.1557317097394032,2.3220517737296262,4.318135223678988,"['SLC30A9', 'SLC39A9', 'SLC30A4']",0.9954001499655907,0,0,3
26,MAPK pathway in congenital thyroid cancer WP4928,0.15585191501212484,3.0945997702029873,5.752393642784229,"['ALK', 'FOS']",0.9954001499655907,0,0,2
27,NAD+ metabolism WP3644,0.15585191501212484,3.0945997702029873,5.752393642784229,"['SIRT5', 'SIRT6']",0.9954001499655907,0,0,2
28,Genes related to primary cilium development (based on CRISPR) WP4536,0.16507316923965862,1.598877761204631,2.880164762183829,"['TTC23', 'DYNLT1', 'TCTN3', 'TCTN1', 'CEP83', 'B9D1', 'TMEM231']",0.9954001499655907,0,0,7
29,RANKL/RANK signaling pathway WP2018,0.18773833451587213,1.844772363303592,3.0857620282653726,"['TRAF6', 'TRAF2', 'FOS', 'TRAF1']",0.9954001499655907,0,0,4
30,Apoptosis Modulation by HSP70 WP384,0.18784107101998135,2.7074396782841825,4.527269734898491,"['CASP9', 'HSPA1A']",0.9954001499655907,0,0,2
31,Benzene metabolism WP3891,0.2023413295683829,5.411646586345381,8.646724896239634,['DHDH'],0.9954001499655907,0,0,1
32,EV release from cardiac cells and their functional effects WP3297,0.2023413295683829,5.411646586345381,8.646724896239634,['MYB'],0.9954001499655907,0,0,1
33,Hfe effect on hepcidin production WP3924,0.2023413295683829,5.411646586345381,8.646724896239634,['HJV'],0.9954001499655907,0,0,1
34,Ebstein-Barr virus LMP1 signaling WP262,0.2041545137607173,2.5480208169058507,4.048494605396815,"['TRAF6', 'TRAF1']",0.9954001499655907,0,0,2
35,B Cell Receptor Signaling Pathway WP23,0.20737506610099862,1.5489025798998846,2.4367741381000525,"['PTPN18', 'INPP5D', 'RAC2', 'E2F3', 'PIK3AP1', 'VAV1']",0.9954001499655907,0,0,6
36,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.2206142803620457,2.406315162347334,3.6367590100918497,"['TRAF6', 'PTGS2']",0.9954001499655907,0,0,2
37,Joubert Syndrome WP4656,0.228776617156801,1.5706985000097529,2.316794773187521,"['TCTN3', 'TMEM138', 'TCTN1', 'B9D1', 'TMEM231']",0.9954001499655907,0,0,5
38,Kit receptor signaling pathway WP304,0.23437086326366277,1.6668734491315136,2.4183842312630075,"['INPP5D', 'FOS', 'MAPT', 'VAV1']",0.9954001499655907,0,0,4
39,Fas ligand pathway and stress induction of heat shock proteins WP314,0.23533984352954945,1.856836049856184,2.6863305155607575,"['CASP9', 'PAK1', 'ARHGDIB']",0.9954001499655907,0,0,3
40,Hematopoietic Stem Cell Differentiation WP2849,0.23533984352954945,1.856836049856184,2.6863305155607575,"['MYB', 'FOS', 'VAV1']",0.9954001499655907,0,0,3
41,T-cell receptor (TCR) signaling pathway WP69,0.2369867831247435,1.5481638146510286,2.2289702560314777,"['ITK', 'PAK1', 'TRAF6', 'FOS', 'VAV1']",0.9954001499655907,0,0,5
42,Metabolism of alpha-linolenic acid WP4586,0.23761045926656366,4.32904953145917,6.221375229785885,['PTGS2'],0.9954001499655907,0,0,1
43,Metastatic brain tumor WP2249,0.23761045926656366,4.32904953145917,6.221375229785885,['E2F3'],0.9954001499655907,0,0,1
44,"Phase I biotransformations, non P450 WP136",0.23761045926656366,4.32904953145917,6.221375229785885,['CES2'],0.9954001499655907,0,0,1
45,Notch Signaling Pathway Netpath WP61,0.24401920050459736,1.6353215662406169,2.306634750597029,"['DLL4', 'CIR1', 'MAPT', 'DLL1']",0.9954001499655907,0,0,4
46,PDGF Pathway WP2526,0.24727506741615066,1.805145413870246,2.5222465214409673,"['PAK1', 'FOS', 'VAV1']",0.9954001499655907,0,0,3
47,NAD+ biosynthetic pathways WP3645,0.25379749733562196,2.165415549597855,2.969258044826304,"['SIRT5', 'SIRT6']",0.9954001499655907,0,0,2
48,PKC-gamma calcium signaling pathway in ataxia WP4760,0.25379749733562196,2.165415549597855,2.969258044826304,"['PLCB3', 'ATP2B2']",0.9954001499655907,0,0,2
49,Nephrotic syndrome WP4758,0.2593003019930118,1.7562488663159803,2.370529260559596,"['NPHS1', 'PODXL', 'E2F3']",0.9954001499655907,0,0,3
50,Proteasome Degradation WP183,0.2635674356862903,1.5756598240469208,2.101057322565382,"['PSMA5', 'PSMB7', 'PSMA3', 'UBE2D2']",0.9954001499655907,0,0,4
51,TLR4 Signaling and Tolerance WP3851,0.27044221671138485,2.0621728584195074,2.696696889469548,"['INPP5D', 'TRAF6']",0.9954001499655907,0,0,2
52,DNA Repair Pathways Full Network WP4946,0.27371138525350797,1.3547570850202428,1.7553331044095017,"['CDK7', 'RFC3', 'WDR48', 'XRCC4', 'ERCC3', 'XRCC5', 'ERCC8']",0.9954001499655907,0,0,7
53,Glucocorticoid Receptor Pathway WP2880,0.28339400255388597,1.5201848707790984,1.9168271206582896,"['GPR153', 'PDE4B', 'SERPINB9', 'PTGS2']",0.9954001499655907,0,0,4
54,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.2870753409068584,1.9683158664391909,2.4564790375184242,"['ITK', 'RASGRP1']",0.9954001499655907,0,0,2
55,Canonical and non-canonical Notch signaling WP3845,0.2870753409068584,1.9683158664391909,2.4564790375184242,"['DLL4', 'DLL1']",0.9954001499655907,0,0,2
56,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.2870753409068584,1.9683158664391909,2.4564790375184242,"['ABCB4', 'ABCB11']",0.9954001499655907,0,0,2
57,Endometrial cancer WP4155,0.29339072009983924,1.4938820912124582,1.8318729780011451,"['CASP9', 'ERBB2', 'FOS', 'FGF1']",0.9954001499655907,0,0,4
58,IL-3 signaling pathway WP286,0.2957616478592043,1.624228187919463,1.9786370406833047,"['INPP5D', 'FOS', 'VAV1']",0.9954001499655907,0,0,3
59,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.2957616478592043,1.624228187919463,1.9786370406833047,"['TRAF6', 'TRAF2', 'FOS']",0.9954001499655907,0,0,3
60,Regulation of Microtubule Cytoskeleton WP2038,0.2957616478592043,1.624228187919463,1.9786370406833047,"['PAK1', 'MAPT', 'PHLDB2']",0.9954001499655907,0,0,3
61,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.29639560506482304,1.4068098792190313,1.7107655219175542,"['CASP9', 'NPY', 'SIRT6', 'TTF2', 'ADCY8']",0.9954001499655907,0,0,5
62,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.3035450211928985,3.091795754446357,3.6861172429300852,['TRAF6'],0.9954001499655907,0,0,1
63,Aspirin and miRNAs WP4707,0.3035450211928985,3.091795754446357,3.6861172429300852,['PTGS2'],0.9954001499655907,0,0,1
64,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.3035450211928985,3.091795754446357,3.6861172429300852,['CUL2'],0.9954001499655907,0,0,1
65,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.3035450211928985,3.091795754446357,3.6861172429300852,['TRAF6'],0.9954001499655907,0,0,1
66,Irinotecan pathway WP229,0.3035450211928985,3.091795754446357,3.6861172429300852,['CES2'],0.9954001499655907,0,0,1
67,Macrophage markers WP4146,0.3035450211928985,3.091795754446357,3.6861172429300852,['RAC2'],0.9954001499655907,0,0,1
68,MTHFR deficiency WP4288,0.3036654118286913,1.8826203520223803,2.2437611600637717,"['CASP9', 'BHMT']",0.9954001499655907,0,0,2
69,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.3236176440298687,1.4201480698043363,1.602200502198296,"['HSPA6', 'UBE2G2', 'HSPA1B', 'HSPA1A']",0.9954001499655907,0,0,4
70,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.3236176440298687,1.4201480698043363,1.602200502198296,"['NPHS1', 'PODXL', 'KRT8', 'FAT1']",0.9954001499655907,0,0,4
71,Pancreatic adenocarcinoma pathway WP4263,0.3313949617013417,1.3370054666600202,1.476648169910305,"['CASP9', 'PAK1', 'ERBB2', 'RAC2', 'E2F3']",0.9954001499655907,0,0,5
72,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.33434480402750116,2.7051539491298526,2.9637192483526302,['DLL1'],0.9954001499655907,0,0,1
73,ATR Signaling WP3875,0.33434480402750116,2.7051539491298526,2.9637192483526302,['ATRIP'],0.9954001499655907,0,0,1
74,Tamoxifen metabolism WP691,0.33434480402750116,2.7051539491298526,2.9637192483526302,['SULT1A1'],0.9954001499655907,0,0,1
75,Bile acids synthesis and enterohepatic circulation  WP4389,0.33434480402750116,2.7051539491298526,2.9637192483526302,['ABCB11'],0.9954001499655907,0,0,1
76,Biotin Metabolism (including IEMs) WP5031,0.33434480402750116,2.7051539491298526,2.9637192483526302,['PCCB'],0.9954001499655907,0,0,1
77,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.33434480402750116,2.7051539491298526,2.9637192483526302,['BLVRA'],0.9954001499655907,0,0,1
78,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.33434480402750116,2.7051539491298526,2.9637192483526302,['CHI3L1'],0.9954001499655907,0,0,1
79,Type II interferon signaling (IFNG) WP619,0.33660435957802676,1.7317962466487935,1.885661226576598,"['IFNGR2', 'IFI6']",0.9954001499655907,0,0,2
80,Gastric Cancer Network 2 WP2363,0.33660435957802676,1.7317962466487935,1.885661226576598,"['RFC3', 'DSCC1']",0.9954001499655907,0,0,2
81,Intraflagellar transport proteins binding to dynein WP4532,0.33660435957802676,1.7317962466487935,1.885661226576598,"['DYNLT1', 'DYNLRB2']",0.9954001499655907,0,0,2
82,Oxidative Stress WP408,0.33660435957802676,1.7317962466487935,1.885661226576598,"['NOX4', 'FOS']",0.9954001499655907,0,0,2
83,Cytosolic DNA-sensing pathway WP4655,0.3569707491462893,1.4433109619686801,1.486756694119869,"['POLR3A', 'POLR3F', 'POLR2F']",0.9954001499655907,0,0,3
84,Selective expression of chemokine receptors during T-cell polarization WP4494,0.3637842462394344,2.404432544994794,2.431348525567296,['IFNGR2'],0.9954001499655907,0,0,1
85,Autosomal recessive Osteopetrosis pathways WP4788,0.3637842462394344,2.404432544994794,2.431348525567296,['TRAF6'],0.9954001499655907,0,0,1
86,Gene regulatory network modelling somitogenesis  WP2854,0.3637842462394344,2.404432544994794,2.431348525567296,['DLL1'],0.9954001499655907,0,0,1
87,LTF danger signal response pathway WP4478,0.3637842462394344,2.404432544994794,2.431348525567296,['TRAF6'],0.9954001499655907,0,0,1
88,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.3637842462394344,2.404432544994794,2.431348525567296,['ERBB2'],0.9954001499655907,0,0,1
89,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.3637842462394344,2.404432544994794,2.431348525567296,['BHMT'],0.9954001499655907,0,0,1
90,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.36916434674793025,1.4118470965859353,1.4069244798430258,"['ITK', 'PAK1', 'FOS']",0.9954001499655907,0,0,3
91,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3743291276632517,1.3121537960247638,1.2893483636925365,"['CASP9', 'RAC2', 'FOS', 'PTGS2']",0.9954001499655907,0,0,4
92,Non-small cell lung cancer WP4255,0.3743291276632517,1.3121537960247638,1.2893483636925365,"['ALK', 'CASP9', 'ERBB2', 'E2F3']",0.9954001499655907,0,0,4
93,Allograft Rejection WP2328,0.3813155222025893,1.3817221190918179,1.3321571273659893,"['CASP9', 'GNLY', 'BHMT2']",0.9954001499655907,0,0,3
94,Mitochondrial complex I assembly model OXPHOS system WP4324,0.3813155222025893,1.3817221190918179,1.3321571273659893,"['COA1', 'ACAD9', 'NDUFAF1']",0.9954001499655907,0,0,3
95,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.3850546256462959,1.5459594025277672,1.4754173831511168,"['TRAF6', 'LY96']",0.9954001499655907,0,0,2
96,Genes controlling nephrogenesis WP4823,0.3850546256462959,1.5459594025277672,1.4754173831511168,"['NPHS1', 'ETV4']",0.9954001499655907,0,0,2
97,Sulfation Biotransformation Reaction WP692,0.39192335315911087,2.163855421686747,2.026859540714687,['SULT1A1'],0.9954001499655907,0,0,1
98,Biogenic Amine Synthesis WP550,0.39192335315911087,2.163855421686747,2.026859540714687,['PAH'],0.9954001499655907,0,0,1
99,Transcriptional cascade regulating adipogenesis WP4211,0.39192335315911087,2.163855421686747,2.026859540714687,['EGR2'],0.9954001499655907,0,0,1
100,Neuroinflammation WP4919,0.39192335315911087,2.163855421686747,2.026859540714687,['FOS'],0.9954001499655907,0,0,1
101,Nuclear Receptors Meta-Pathway WP2882,0.3943048940008363,1.1203616941529235,1.0426431291892497,"['SULT1A1', 'DNAJB1', 'GPR153', 'SLC39A9', 'ABCB4', 'MYOF', 'PDE4B', 'SERPINB9', 'ABCB11', 'PTGS2', 'CES2', 'HSPA1A']",0.9954001499655907,0,0,12
102,Fluoropyrimidine Activity WP1601,0.4008699948227745,1.4925580105389664,1.364374302700232,"['RRM2', 'CES2']",0.9954001499655907,0,0,2
103,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.4008699948227745,1.4925580105389664,1.364374302700232,"['TRAF6', 'FOS']",0.9954001499655907,0,0,2
104,Prolactin Signaling Pathway WP2037,0.4046475179383727,1.2548698768895121,1.1353296132766422,"['PAK1', 'ERBB2', 'FOS', 'VAV1']",0.9954001499655907,0,0,4
105,Spinal Cord Injury WP2431,0.4109698465881186,1.202631972483924,1.0694229629633203,"['NOX4', 'FOS', 'PDYN', 'PTGS2', 'E2F5']",0.9954001499655907,0,0,5
106,Neural Crest Cell Migration during Development WP4564,0.4164907655462259,1.442716711349419,1.2636625674085027,"['PAK1', 'FOS']",0.9954001499655907,0,0,2
107,Modulators of TCR signaling and T cell activation WP5072,0.41741540104848995,1.2985771812080538,1.1345323247623456,"['ITK', 'TRAF6', 'VAV1']",0.9954001499655907,0,0,3
108,Serotonin and anxiety-related events WP3944,0.41881948678696085,1.9670195935256176,1.7119271906279538,['FOS'],0.9954001499655907,0,0,1
109,Disorders of Folate Metabolism and Transport WP4259,0.41881948678696085,1.9670195935256176,1.7119271906279538,['ATIC'],0.9954001499655907,0,0,1
110,Drug Induction of Bile Acid Pathway WP2289,0.41881948678696085,1.9670195935256176,1.7119271906279538,['ABCB11'],0.9954001499655907,0,0,1
111,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.41881948678696085,1.9670195935256176,1.7119271906279538,['TRAF6'],0.9954001499655907,0,0,1
112,NO metabolism in cystic fibrosis WP4947,0.41881948678696085,1.9670195935256176,1.7119271906279538,['PRMT8'],0.9954001499655907,0,0,1
113,RalA downstream regulated genes WP2290,0.41881948678696085,1.9670195935256176,1.7119271906279538,['RAC2'],0.9954001499655907,0,0,1
114,Type 2 papillary renal cell carcinoma WP4241,0.4319032353466796,1.39609097984952,1.1720933589512332,"['CUL2', 'VHL']",0.9954001499655907,0,0,2
115,Disruption of postsynaptic signaling by CNV WP4875,0.4319032353466796,1.39609097984952,1.1720933589512332,"['SYNGAP1', 'HOMER1']",0.9954001499655907,0,0,2
116,Melatonin metabolism and effects WP3298,0.4319032353466796,1.39609097984952,1.1720933589512332,"['SULT1A1', 'TRAF6']",0.9954001499655907,0,0,2
117,Apoptosis Modulation and Signaling WP1772,0.43467758493199604,1.2023596176821982,1.0017467652642775,"['CASP9', 'TRAF6', 'FOS', 'HSPA1A']",0.9954001499655907,0,0,4
118,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.44452748193711206,1.8029897367246766,1.461762028071749,['TRAF6'],0.9954001499655907,0,0,1
119,Ganglio Sphingolipid Metabolism WP1423,0.44452748193711206,1.8029897367246766,1.461762028071749,['B3GALT4'],0.9954001499655907,0,0,1
120,GPR40 Pathway WP3958,0.44452748193711206,1.8029897367246766,1.461762028071749,['PLCB3'],0.9954001499655907,0,0,1
121,Major receptors targeted by epinephrine and norepinephrine WP4589,0.44452748193711206,1.8029897367246766,1.461762028071749,['ADCY8'],0.9954001499655907,0,0,1
122,Signaling of Hepatocyte Growth Factor Receptor WP313,0.44709528970631096,1.3523793565683646,1.0886431097162468,"['PAK1', 'FOS']",0.9954001499655907,0,0,2
123,Microglia Pathogen Phagocytosis Pathway WP3937,0.44709528970631096,1.3523793565683646,1.0886431097162468,"['RAC2', 'VAV1']",0.9954001499655907,0,0,2
124,Parkinson's disease pathway WP2371,0.44709528970631096,1.3523793565683646,1.0886431097162468,"['CASP9', 'UBE2G2']",0.9954001499655907,0,0,2
125,Neural Crest Cell Migration in Cancer WP4565,0.4620562889370875,1.3113169225769763,1.0124265652272635,"['PAK1', 'FOS']",0.9954001499655907,0,0,2
126,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.4620562889370875,1.3113169225769763,1.0124265652272635,"['CREB3L2', 'CREB5']",0.9954001499655907,0,0,2
127,Thermogenesis WP4321,0.46337862888622716,1.1270468820098698,0.8669366181022279,"['SLC25A29', 'CREB3L2', 'SIRT6', 'ADCY8', 'CREB5']",0.9954001499655907,0,0,5
128,Cysteine and methionine catabolism WP4504,0.46909975738609105,1.6641952425084956,1.259695665345833,['BHMT'],0.9954001499655907,0,0,1
129,Galanin receptor pathway WP4970,0.46909975738609105,1.6641952425084956,1.259695665345833,['FOS'],0.9954001499655907,0,0,1
130,Mammalian disorder of sexual development WP4842,0.46909975738609105,1.6641952425084956,1.259695665345833,['SRD5A1'],0.9954001499655907,0,0,1
131,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.46909975738609105,1.6641952425084956,1.259695665345833,['SAMHD1'],0.9954001499655907,0,0,1
132,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.4758875397614941,1.1801586333129956,0.8763547790589542,"['PAK1', 'FZD4', 'ERBB2']",0.9954001499655907,0,0,3
133,Differentiation Pathway WP2848,0.47677696159549626,1.272669925879199,0.9426748650721062,"['ALK', 'FGF1']",0.9954001499655907,0,0,2
134,IL-2 signaling pathway WP49,0.47677696159549626,1.272669925879199,0.9426748650721062,"['FOS', 'MAPT']",0.9954001499655907,0,0,2
135,Chemokine signaling pathway WP3929,0.47775784942748734,1.0909646877618973,0.8058424477844943,"['ITK', 'PLCB3', 'PAK1', 'RAC2', 'ADCY8', 'VAV1']",0.9954001499655907,0,0,6
136,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.4912493047366328,1.2362313289927231,0.8787175938971225,"['TRAF2', 'TRAF1']",0.9954001499655907,0,0,2
137,IL-5 signaling pathway WP127,0.4912493047366328,1.2362313289927231,0.8787175938971225,"['FOS', 'MAPT']",0.9954001499655907,0,0,2
138,Oxidation by Cytochrome P450 WP43,0.4912493047366328,1.2362313289927231,0.8787175938971225,"['CYP4X1', 'CYP20A1']",0.9954001499655907,0,0,2
139,Biomarkers for pyrimidine metabolism disorders WP4584,0.4925864224289429,1.5452285331803404,1.0941536971791375,['RRM2'],0.9954001499655907,0,0,1
140,Overview of nanoparticle effects WP3287,0.4925864224289429,1.5452285331803404,1.0941536971791375,['PTGS2'],0.9954001499655907,0,0,1
141,Retinoblastoma gene in cancer WP2446,0.4932967009972334,1.1094568513923353,0.7839915358530464,"['RFC3', 'RRM2', 'KIF4A', 'E2F3']",0.9954001499655907,0,0,4
142,Hepatitis B infection WP4666,0.5008526802779636,1.0639388449471963,0.7356533566691307,"['CASP9', 'EGR2', 'TRAF6', 'CREB3L2', 'FOS', 'CREB5']",0.9954001499655907,0,0,6
143,Ferroptosis WP4313,0.5054664899795387,1.2018170985999403,0.8199679985553415,"['LPCAT3', 'SLC3A2']",0.9954001499655907,0,0,2
144,Serotonin and anxiety WP3947,0.515035378208779,1.442124051762606,0.9568776967393166,['FOS'],0.9954001499655907,0,0,1
145,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.515035378208779,1.442124051762606,0.9568776967393166,['SIRT6'],0.9954001499655907,0,0,1
146,Glycosaminoglycan degradation WP4815,0.515035378208779,1.442124051762606,0.9568776967393166,['GNS'],0.9954001499655907,0,0,1
147,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.515035378208779,1.442124051762606,0.9568776967393166,['THRAP3'],0.9954001499655907,0,0,1
148,Overview of interferons-mediated signaling pathway WP4558,0.515035378208779,1.442124051762606,0.9568776967393166,['IFNGR2'],0.9954001499655907,0,0,1
149,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.531498112789274,1.081476510067114,0.6835533189902667,"['CASP9', 'PAK1', 'ERBB2']",0.9954001499655907,0,0,3
150,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.536492414867077,1.3519076305220883,0.8418367414794181,['TNC'],0.9954001499655907,0,0,1
151,Pyrimidine metabolism and related diseases WP4225,0.536492414867077,1.3519076305220883,0.8418367414794181,['RRM2'],0.9954001499655907,0,0,1
152,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.5422188131640396,1.0636813730883485,0.6510640989898201,"['KCNIP3', 'TTF2', 'FOS']",0.9954001499655907,0,0,3
153,Melanoma WP4685,0.5422188131640396,1.0636813730883485,0.6510640989898201,"['PAK1', 'E2F3', 'FOS']",0.9954001499655907,0,0,3
154,Breast cancer pathway WP4262,0.5458846150446087,1.0136876684636118,0.6136334513111841,"['DLL4', 'ERBB2', 'E2F3', 'FOS', 'FGF1', 'DLL1']",0.9954001499655907,0,0,6
155,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.5527962829478166,1.0464602727863175,0.6203057881383709,"['SEC13', 'NFYA', 'SEC23B']",0.9954001499655907,0,0,3
156,15q13.3 copy number variation syndrome WP4942,0.557001304891257,1.2723049058981022,0.744537176930175,['SERPINH1'],0.9954001499655907,0,0,1
157,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.557001304891257,1.2723049058981022,0.744537176930175,['SDHB'],0.9954001499655907,0,0,1
158,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.557001304891257,1.2723049058981022,0.744537176930175,['TRAF6'],0.9954001499655907,0,0,1
159,Nanomaterial induced apoptosis WP2507,0.557001304891257,1.2723049058981022,0.744537176930175,['CASP9'],0.9954001499655907,0,0,1
160,Notch Signaling WP268,0.5596834239990319,1.0813672922252011,0.6276082414309931,"['DLL4', 'DLL1']",0.9954001499655907,0,0,2
161,Acute viral myocarditis WP4298,0.5632272303349046,1.029785874081176,0.5911713660491348,"['CASP9', 'RAC2', 'KRT8']",0.9954001499655907,0,0,3
162,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.5766038913564139,1.201546928454559,0.6615714324168163,['RASGRP1'],0.9954001499655907,0,0,1
163,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.5766038913564139,1.201546928454559,0.6615714324168163,['CASP9'],0.9954001499655907,0,0,1
164,16p11.2 proximal deletion syndrome WP4949,0.5836381157370902,0.9979762519359835,0.5373844170344869,"['PAGR1', 'TRAF6', 'TRAF2']",0.9954001499655907,0,0,3
165,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.585155853139091,1.029745946636027,0.5518172217909125,"['SYNE4', 'ADCY8']",0.9954001499655907,0,0,2
166,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.585155853139091,1.029745946636027,0.5518172217909125,"['TRAF6', 'TRAF2']",0.9954001499655907,0,0,2
167,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.589023351025847,0.9679365973367663,0.5123186301212589,"['EGR2', 'DOK5', 'TRAF6', 'FOS', 'MAPT', 'SH2B1']",0.9954001499655907,0,0,6
168,Apoptosis WP254,0.5936131514821938,0.9827943868212324,0.5125542326568759,"['CASP9', 'TRAF2', 'TRAF1']",0.9954001499655907,0,0,3
169,Vitamin D in inflammatory diseases WP4482,0.5953401732277223,1.1382371591629676,0.5903151928892962,['DUSP1'],0.9954001499655907,0,0,1
170,Globo Sphingolipid Metabolism WP1424,0.5953401732277223,1.1382371591629676,0.5903151928892962,['FUT2'],0.9954001499655907,0,0,1
171,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.5953401732277223,1.1382371591629676,0.5903151928892962,['SGMS2'],0.9954001499655907,0,0,1
172,Methionine De Novo and Salvage Pathway WP3580,0.5953401732277223,1.1382371591629676,0.5903151928892962,['BHMT'],0.9954001499655907,0,0,1
173,"Relationship between inflammation, COX-2 and EGFR WP4483",0.5953401732277223,1.1382371591629676,0.5903151928892962,['PTGS2'],0.9954001499655907,0,0,1
174,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6095216759864139,0.9828174506458689,0.4865740174231244,"['PPP1R10', 'PPP1R3A']",0.9954001499655907,0,0,2
175,Histone Modifications WP2369,0.6095216759864139,0.9828174506458689,0.4865740174231244,"['KMT5C', 'PRDM2']",0.9954001499655907,0,0,2
176,Head and Neck Squamous Cell Carcinoma WP4674,0.6130924625130634,0.9537702329253849,0.4666220893701495,"['SESN2', 'ERBB2', 'FAT1']",0.9954001499655907,0,0,3
177,Eicosanoid Synthesis WP167,0.613248386428149,1.0812583668005356,0.5287193679660653,['PTGS2'],0.9954001499655907,0,0,1
178,Immune response to tuberculosis WP4197,0.613248386428149,1.0812583668005356,0.5287193679660653,['IFNGR2'],0.9954001499655907,0,0,1
179,Kallmann's Syndrome WP5074,0.613248386428149,1.0812583668005356,0.5287193679660653,['CHD7'],0.9954001499655907,0,0,1
180,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.613248386428149,1.0812583668005356,0.5287193679660653,['SIRT5'],0.9954001499655907,0,0,1
181,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.6212894985542103,0.9609174858504618,0.45735648429801207,"['TRAF6', 'FOS']",0.9954001499655907,0,0,2
182,Toll-like Receptor Signaling Pathway WP75,0.6225936245611804,0.9398891158447622,0.44537704168217823,"['TRAF6', 'LY96', 'FOS']",0.9954001499655907,0,0,3
183,Constitutive Androstane Receptor Pathway WP2875,0.6303650813558306,1.0297061260916682,0.4751642073021811,['SULT1A1'],0.9954001499655907,0,0,1
184,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.6303650813558306,1.0297061260916682,0.4751642073021811,['PTGS2'],0.9954001499655907,0,0,1
185,Estrogen signaling pathway WP712,0.6303650813558306,1.0297061260916682,0.4751642073021811,['FOS'],0.9954001499655907,0,0,1
186,Nanoparticle triggered autophagic cell death WP2509,0.6303650813558306,1.0297061260916682,0.4751642073021811,['CHAF1A'],0.9954001499655907,0,0,1
187,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6303650813558306,1.0297061260916682,0.4751642073021811,['FOS'],0.9954001499655907,0,0,1
188,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.6327816087104342,0.9399696934374636,0.4301582615355021,"['SYNGAP1', 'HOMER1']",0.9954001499655907,0,0,2
189,IL-4 signaling pathway WP395,0.6327816087104342,0.9399696934374636,0.4301582615355021,"['INPP5D', 'FOS']",0.9954001499655907,0,0,2
190,Phosphoinositides metabolism WP4971,0.6327816087104342,0.9399696934374636,0.4301582615355021,"['PLCB3', 'INPP5D']",0.9954001499655907,0,0,2
191,Ciliopathies WP4803,0.6417154987539023,0.9165582955056639,0.4065946288259058,"['TMEM138', 'TCTN3', 'TCTN1', 'CEP83', 'HYLS1', 'B9D1', 'TMEM231']",0.9954001499655907,0,0,7
192,Sphingolipid Metabolism (general overview) WP4725,0.6467251972184982,0.9828404527199708,0.4283550976824956,['SGMS2'],0.9954001499655907,0,0,1
193,DNA Mismatch Repair WP531,0.6467251972184982,0.9828404527199708,0.4283550976824956,['RFC3'],0.9954001499655907,0,0,1
194,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6467251972184982,0.9828404527199708,0.4283550976824956,['CASP9'],0.9954001499655907,0,0,1
195,Signal Transduction of S1P Receptor WP26,0.6623621329566538,0.9400500552936383,0.3872468932568202,['PLCB3'],0.9954001499655907,0,0,1
196,Sphingolipid Metabolism (integrated pathway) WP4726,0.6623621329566538,0.9400500552936383,0.3872468932568202,['SGMS2'],0.9954001499655907,0,0,1
197,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6623621329566538,0.9400500552936383,0.3872468932568202,['TRAF6'],0.9954001499655907,0,0,1
198,miRNAs involvement in the immune response in sepsis WP4329,0.6623621329566538,0.9400500552936383,0.3872468932568202,['TRAF6'],0.9954001499655907,0,0,1
199,Physiological and pathological hypertrophy of the heart WP1528,0.6623621329566538,0.9400500552936383,0.3872468932568202,['FOS'],0.9954001499655907,0,0,1
200,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.6656192058534378,0.8822563878098156,0.35911146528214094,"['TRAF1', 'HSPD1']",0.9954001499655907,0,0,2
201,Translation Factors WP107,0.6656192058534378,0.8822563878098156,0.35911146528214094,"['EIF5B', 'EIF2B1']",0.9954001499655907,0,0,2
202,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.6656192058534378,0.8822563878098156,0.35911146528214094,"['TRAF6', 'TRAF2']",0.9954001499655907,0,0,2
203,Phosphodiesterases in neuronal function WP4222,0.6656192058534378,0.8822563878098156,0.35911146528214094,"['PDE4B', 'ADCY8']",0.9954001499655907,0,0,2
204,Alzheimer's disease WP2059,0.6676755612687288,0.8761110103391982,0.3539075922435617,"['CASP9', 'PLCB3', 'MAPT']",0.9954001499655907,0,0,3
205,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.6730804224535444,0.8781691450831063,0.3476587850762498,"['ADCYAP1', 'NFYA', 'PAH', 'MYB', 'HSPD1']",0.9954001499655907,0,0,5
206,Osteoblast differentiation WP4787,0.6731470052372315,0.872977082654502,0.34551694431752766,"['DLL4', 'FZD4', 'FGF1', 'DLL1']",0.9954001499655907,0,0,4
207,Regulation of toll-like receptor signaling pathway WP1449,0.6731470052372315,0.872977082654502,0.34551694431752766,"['TRAF6', 'TRAFD1', 'LY96', 'FOS']",0.9954001499655907,0,0,4
208,DNA IR-damage and cellular response via ATR WP4016,0.6762040409722649,0.8643758389261745,0.33819604748745574,"['XRCC5', 'RECQL', 'ATRIP']",0.9954001499655907,0,0,3
209,Striated Muscle Contraction Pathway WP383,0.67730781481954,0.9008255243195002,0.35098813974335324,['TPM4'],0.9954001499655907,0,0,1
210,Cell migration and invasion through p75NTR WP4561,0.67730781481954,0.9008255243195002,0.35098813974335324,['PAK1'],0.9954001499655907,0,0,1
211,Ovarian infertility WP34,0.67730781481954,0.9008255243195002,0.35098813974335324,['DMC1'],0.9954001499655907,0,0,1
212,Photodynamic therapy-induced unfolded protein response WP3613,0.67730781481954,0.9008255243195002,0.35098813974335324,['DNAJC3'],0.9954001499655907,0,0,1
213,Male infertility WP4673,0.6805098259107736,0.8641935483870967,0.3326393466238586,"['BHMT', 'XRCC4', 'XRCC5', 'MOV10L1']",0.9954001499655907,0,0,4
214,Amino Acid metabolism WP3925,0.6845698179151681,0.8529494878134934,0.32323769647446776,"['BHMT', 'RARS', 'IARS']",0.9954001499655907,0,0,3
215,EGF/EGFR signaling pathway WP437,0.6866207655098905,0.8696792633730711,0.3269760560064351,"['PAK1', 'INPP5D', 'ERBB2', 'STAMBP', 'FOS', 'VAV1']",0.9954001499655907,0,0,6
216,Signal transduction through IL1R WP4496,0.6915927616937759,0.8647389558232932,0.3188794003115849,['TRAF6'],0.9954001499655907,0,0,1
217,Toll-like Receptor Signaling related to MyD88 WP3858,0.6915927616937759,0.8647389558232932,0.3188794003115849,['TRAF6'],0.9954001499655907,0,0,1
218,White fat cell differentiation WP4149,0.6915927616937759,0.8647389558232932,0.3188794003115849,['EGR2'],0.9954001499655907,0,0,1
219,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.6915927616937759,0.8647389558232932,0.3188794003115849,['ERBB2'],0.9954001499655907,0,0,1
220,DNA IR-double strand breaks and cellular response via ATM WP3959,0.696047019700697,0.8312023097545885,0.30117623561601065,"['CASP9', 'TRAF6']",0.9954001499655907,0,0,2
221,Focal Adhesion WP306,0.7043831224924623,0.8586829836829837,0.3009107361802452,"['MYL5', 'PAK1', 'LAMA1', 'ERBB2', 'RAC2', 'TNC', 'VAV1']",0.9954001499655907,0,0,7
222,IL17 signaling pathway WP2112,0.7052461466415711,0.8314282772114098,0.29034173252493906,['TRAF6'],0.9954001499655907,0,0,1
223,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7052461466415711,0.8314282772114098,0.29034173252493906,['EGR2'],0.9954001499655907,0,0,1
224,Resistin as a regulator of inflammation WP4481,0.7052461466415711,0.8314282772114098,0.29034173252493906,['PLCB3'],0.9954001499655907,0,0,1
225,Neural Crest Differentiation WP2064,0.7086952546741716,0.820406082745731,0.28249015492217927,"['DLL4', 'MYB', 'DLL1']",0.9954001499655907,0,0,3
226,Pyrimidine metabolism WP4022,0.7086952546741716,0.820406082745731,0.28249015492217927,"['RRM2', 'POLR3A', 'POLR3F']",0.9954001499655907,0,0,3
227,Ciliary landscape WP4352,0.7153640627369707,0.8548033181696548,0.2863280713041243,"['EIF5B', 'DYNLT1', 'EIPR1', 'UBE2D2', 'MCM9', 'DYNLRB2', 'CNOT9', 'SNAP29']",0.9954001499655907,0,0,8
228,NRF2 pathway WP2884,0.7155713299588702,0.8227854582693293,0.27536489428119043,"['DNAJB1', 'SLC39A9', 'CES2', 'HSPA1A']",0.9954001499655907,0,0,4
229,Aryl Hydrocarbon Receptor Pathway WP2873,0.7182958562737175,0.8005850562744806,0.26489257072824096,['MYOF'],0.9954001499655907,0,0,1
230,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.7182958562737175,0.8005850562744806,0.26489257072824096,['SERPINH1'],0.9954001499655907,0,0,1
231,Endothelin Pathways WP2197,0.7182958562737175,0.8005850562744806,0.26489257072824096,['NPY'],0.9954001499655907,0,0,1
232,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.7182958562737175,0.8005850562744806,0.26489257072824096,['ERBB2'],0.9954001499655907,0,0,1
233,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7182958562737175,0.8005850562744806,0.26489257072824096,['FGF1'],0.9954001499655907,0,0,1
234,PDGFR-beta pathway WP3972,0.7182958562737175,0.8005850562744806,0.26489257072824096,['FOS'],0.9954001499655907,0,0,1
235,Myometrial relaxation and contraction pathways WP289,0.7236254267770383,0.8241295346901873,0.26659056478987353,"['PLCB3', 'RGS3', 'PDE4B', 'FOS', 'ADCY8']",0.9954001499655907,0,0,5
236,MET in type 1 papillary renal cell carcinoma WP4205,0.7241472454325705,0.7857177674872045,0.25359868275466757,"['ALK', 'PAK1']",0.9954001499655907,0,0,2
237,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7295311653596239,0.8178351482523757,0.2579069232202334,"['DLL4', 'PAK1', 'FZD4', 'TRAF6', 'DLL1']",0.9954001499655907,0,0,5
238,Sphingolipid pathway WP1422,0.730768547468519,0.7719449225473322,0.24212708177883516,['SGMS2'],0.9954001499655907,0,0,1
239,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.730768547468519,0.7719449225473322,0.24212708177883516,['CASP9'],0.9954001499655907,0,0,1
240,"GPCRs, Other WP117",0.7330136528050121,0.7716392186901571,0.23966415902518323,"['GPR143', 'ALG6']",0.9954001499655907,0,0,2
241,Regulation of Actin Cytoskeleton WP51,0.7353452358978506,0.8116354142422004,0.24950904805394628,"['PAK1', 'ABI2', 'RAC2', 'FGF1', 'VAV1']",0.9954001499655907,0,0,5
242,Sleep regulation WP3591,0.7426897015811887,0.7452799704565388,0.22170361294896582,['FOS'],0.9954001499655907,0,0,1
243,GABA receptor Signaling WP4159,0.7426897015811887,0.7452799704565388,0.22170361294896582,['GABRQ'],0.9954001499655907,0,0,1
244,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7426897015811887,0.7452799704565388,0.22170361294896582,['CASP9'],0.9954001499655907,0,0,1
245,G Protein Signaling Pathways WP35,0.7457135410525902,0.7713326941514861,0.22631961501022999,"['PLCB3', 'PDE4B', 'ADCY8']",0.9954001499655907,0,0,3
246,p53 transcriptional gene network WP4963,0.7500200003789416,0.7449385226957567,0.21428559291949956,"['XRCC5', 'SESN2']",0.9954001499655907,0,0,2
247,TNF-alpha signaling pathway WP231,0.7526488813422638,0.7622108172127912,0.2165871222336459,"['CASP9', 'TRAF2', 'TRAF1']",0.9954001499655907,0,0,3
248,Wnt signaling in kidney disease WP4150,0.754083676096784,0.7203926818384649,0.20333223264170758,['FZD4'],0.9954001499655907,0,0,1
249,Neovascularisation processes WP4331,0.754083676096784,0.7203926818384649,0.20333223264170758,['DLL4'],0.9954001499655907,0,0,1
250,G1 to S cell cycle control WP45,0.758168395788755,0.7322670059526515,0.20272794483966658,"['CDK7', 'E2F3']",0.9954001499655907,0,0,2
251,miRNA regulation of prostate cancer signaling pathways WP3981,0.7649737542203224,0.6971110247441379,0.1867656315611341,['CASP9'],0.9954001499655907,0,0,1
252,Pathways affected in adenoid cystic carcinoma WP3651,0.7737774674757859,0.7081703511624841,0.18162512729391705,"['MYB', 'ERBB2']",0.9954001499655907,0,0,2
253,Alpha 6 Beta 4 signaling pathway WP244,0.7753821920753093,0.6752844712182061,0.1717918428390153,['LAMA1'],0.9954001499655907,0,0,1
254,Amyotrophic lateral sclerosis (ALS) WP2447,0.7753821920753093,0.6752844712182061,0.1717918428390153,['CASP9'],0.9954001499655907,0,0,1
255,BDNF-TrkB Signaling WP3676,0.7753821920753093,0.6752844712182061,0.1717918428390153,['HOMER1'],0.9954001499655907,0,0,1
256,MAPK Cascade WP422,0.7753821920753093,0.6752844712182061,0.1717918428390153,['PLCB3'],0.9954001499655907,0,0,1
257,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7753821920753093,0.6752844712182061,0.1717918428390153,['PTGS2'],0.9954001499655907,0,0,1
258,DNA damage response WP707,0.7812470903276235,0.6967050073510335,0.17199124720943487,"['CASP9', 'ATRIP']",0.9954001499655907,0,0,2
259,Mesodermal commitment pathway WP2857,0.7825447317538539,0.7442528735632183,0.18249392526566766,"['WDHD1', 'FZD4', 'HPRT1', 'DLL1']",0.9954001499655907,0,0,4
260,Metapathway biotransformation Phase I and II WP702,0.7825447317538539,0.7442528735632183,0.18249392526566766,"['SULT1A1', 'GSTK1', 'CYP4X1', 'CYP20A1']",0.9954001499655907,0,0,4
261,p38 MAPK Signaling Pathway WP400,0.7853302640170491,0.6547807391180885,0.15822837532915696,['TRAF2'],0.9954001499655907,0,0,1
262,Pre-implantation embryo WP3527,0.7853302640170491,0.6547807391180885,0.15822837532915696,['E2F5'],0.9954001499655907,0,0,1
263,Bladder cancer WP2828,0.7948383060806228,0.6354831089062131,0.1459174540425728,['ERBB2'],0.9954001499655907,0,0,1
264,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7948383060806228,0.6354831089062131,0.1459174540425728,['FOS'],0.9954001499655907,0,0,1
265,miRNA regulation of DNA damage response WP1530,0.7955392323130692,0.6748491957104558,0.15436170812961272,"['CASP9', 'ATRIP']",0.9954001499655907,0,0,2
266,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.8039257569371551,0.6172882004207305,0.13472213503417982,['PLCB3'],0.9954001499655907,0,0,1
267,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.8039257569371551,0.6172882004207305,0.13472213503417982,['GABRQ'],0.9954001499655907,0,0,1
268,Vitamin D-sensitive calcium signaling in depression WP4698,0.8126111978228265,0.6001041201844415,0.1245231143703836,['ATP2B2'],0.9954001499655907,0,0,1
269,Development of ureteric collection system WP5053,0.8126111978228265,0.6001041201844415,0.1245231143703836,['ETV4'],0.9954001499655907,0,0,1
270,G13 Signaling Pathway WP524,0.8126111978228265,0.6001041201844415,0.1245231143703836,['ARHGDIB'],0.9954001499655907,0,0,1
271,TGF-beta Signaling Pathway WP366,0.8134388479209673,0.7073858628591574,0.1460642351058256,"['TRAF6', 'TNC', 'FOS', 'E2F5']",0.9954001499655907,0,0,4
272,mRNA Processing WP411,0.8134388479209673,0.7073858628591574,0.1460642351058256,"['CPSF3', 'SNRPA1', 'SNRPF', 'RBMX']",0.9954001499655907,0,0,4
273,Insulin Signaling WP481,0.8205037176880551,0.7188873934499775,0.14222240840938974,"['RRAD', 'RAC2', 'PPP1R3A', 'FOS', 'SGK2']",0.9954001499655907,0,0,5
274,Vitamin A and carotenoid metabolism WP716,0.820912389933535,0.583848909150114,0.11521609369321403,['SULT1A1'],0.9954001499655907,0,0,1
275,Glycolysis and Gluconeogenesis WP534,0.820912389933535,0.583848909150114,0.11521609369321403,['FBP2'],0.9954001499655907,0,0,1
276,Lung fibrosis WP3624,0.820912389933535,0.583848909150114,0.11521609369321403,['FGF1'],0.9954001499655907,0,0,1
277,Prostaglandin Synthesis and Regulation WP98,0.820912389933535,0.583848909150114,0.11521609369321403,['PTGS2'],0.9954001499655907,0,0,1
278,ESC Pluripotency Pathways WP3931,0.8295611014431917,0.6605670456101904,0.12343257488470298,"['FZD4', 'FOS', 'FGF1']",0.9954001499655907,0,0,3
279,Aryl Hydrocarbon Receptor Netpath WP2586,0.8364291892005555,0.5538392887790479,0.09892312585649989,['PTGS2'],0.9954001499655907,0,0,1
280,Common Pathways Underlying Drug Addiction WP2636,0.8364291892005555,0.5538392887790479,0.09892312585649989,['ADCY8'],0.9954001499655907,0,0,1
281,DNA Replication WP466,0.8364291892005555,0.5538392887790479,0.09892312585649989,['RFC3'],0.9954001499655907,0,0,1
282,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8364291892005555,0.5538392887790479,0.09892312585649989,['CASP9'],0.9954001499655907,0,0,1
283,Leptin signaling pathway WP2034,0.839249631330519,0.6080504474568591,0.10655906687280983,"['ERBB2', 'SH2B1']",0.9954001499655907,0,0,2
284,Splicing factor NOVA regulated synaptic proteins WP4148,0.8436765369625878,0.5399598393574297,0.09178567150904952,['NTNG1'],0.9954001499655907,0,0,1
285,IL-6 signaling pathway WP364,0.8436765369625878,0.5399598393574297,0.09178567150904952,['VAV1'],0.9954001499655907,0,0,1
286,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.8436765369625878,0.5399598393574297,0.09178567150904952,['PAK1'],0.9954001499655907,0,0,1
287,Metabolic reprogramming in colon cancer WP4290,0.8436765369625878,0.5399598393574297,0.09178567150904952,['SDHB'],0.9954001499655907,0,0,1
288,Gastrin signaling pathway WP4659,0.848685521268883,0.6345045400710619,0.10410098483641203,"['PAK1', 'FOS', 'PTGS2']",0.9954001499655907,0,0,3
289,Integrated Cancer Pathway WP1971,0.850603181923207,0.5267574362490612,0.08523438654787968,['CASP9'],0.9954001499655907,0,0,1
290,PI3K-Akt signaling pathway WP4172,0.8515742030094808,0.7396419754361682,0.11883726939363139,"['CASP9', 'LAMA1', 'MYB', 'CREB3L2', 'TNC', 'FGF1', 'PIK3AP1', 'SGK2', 'CREB5']",0.9954001499655907,0,0,9
291,Calcium Regulation in the Cardiac Cell WP536,0.8529508266488767,0.6584174669621604,0.10472352402670443,"['PLCB3', 'RGS3', 'ATP2B2', 'ADCY8']",0.9954001499655907,0,0,4
292,TGF-beta Receptor Signaling WP560,0.8572232973862081,0.5141837190029961,0.07921351753048617,['FOS'],0.9954001499655907,0,0,1
293,Netrin-UNC5B signaling pathway WP4747,0.8572232973862081,0.5141837190029961,0.07921351753048617,['INPP5D'],0.9954001499655907,0,0,1
294,Peptide GPCRs WP24,0.8572232973862081,0.5141837190029961,0.07921351753048617,['NPY5R'],0.9954001499655907,0,0,1
295,Corticotropin-releasing hormone signaling pathway WP2355,0.8743235074709989,0.5532412181205747,0.07430296551681949,"['CASP9', 'FOS']",0.9954001499655907,0,0,2
296,TYROBP causal network in microglia WP3945,0.8753769794768624,0.47981555853041796,0.06386376354524982,['CREB3L2'],0.9954001499655907,0,0,1
297,Proximal tubule transport WP4917,0.8753769794768624,0.47981555853041796,0.06386376354524982,['SLC3A2'],0.9954001499655907,0,0,1
298,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8809006041162568,0.46935568360398117,0.05951922003181863,['FOS'],0.9954001499655907,0,0,1
299,Exercise-induced Circadian Regulation WP410,0.8809006041162568,0.46935568360398117,0.05951922003181863,['HIST1H2BN'],0.9954001499655907,0,0,1
300,Cell cycle WP179,0.8813955362109436,0.5880658938377059,0.07424260813568895,"['CDK7', 'E2F3', 'E2F5']",0.9954001499655907,0,0,3
301,Integrated breast cancer pathway WP1984,0.8851279465446725,0.6157450076804916,0.07513509744088749,"['UBE2F', 'CASP9', 'CDK7', 'PAK1']",0.9954001499655907,0,0,4
302,Rett syndrome causing genes WP4312,0.886179715453041,0.45934090973824376,0.05550469301599158,['SYNGAP1'],0.9954001499655907,0,0,1
303,Pathways in clear cell renal cell carcinoma WP4018,0.8870789963815453,0.5326515076291662,0.06382296437491436,"['EFCAB3', 'VHL']",0.9954001499655907,0,0,2
304,Copper homeostasis WP3286,0.8912251233813181,0.4497434181169121,0.05179165135114781,['MAPT'],0.9954001499655907,0,0,1
305,Fragile X Syndrome  WP4549,0.8952643522508184,0.5672907099964677,0.06276291038970683,"['SYNGAP1', 'HOMER1', 'TTI1']",0.9954001499655907,0,0,3
306,Vitamin D Receptor Pathway WP2877,0.8984960032920345,0.5623227312518237,0.060187100685259905,"['STS', 'COL13A1', 'RASGRP1']",0.9954001499655907,0,0,3
307,Interferon type I signaling pathways WP585,0.9006557036462863,0.43170013386880857,0.045169743951506566,['VAV1'],0.9954001499655907,0,0,1
308,Pathogenic Escherichia coli infection WP2272,0.9006557036462863,0.43170013386880857,0.045169743951506566,['LY96'],0.9954001499655907,0,0,1
309,ErbB signaling pathway WP673,0.902223654196183,0.5074593912632077,0.052213935922227464,"['PAK1', 'ERBB2']",0.9954001499655907,0,0,2
310,Cardiac Hypertrophic Response WP2795,0.9050601925113766,0.4232091765755834,0.04221673474441453,['CDK7'],0.9954001499655907,0,0,1
311,Genotoxicity pathway WP4286,0.9050601925113766,0.4232091765755834,0.04221673474441453,['HIST1H2BN'],0.9954001499655907,0,0,1
312,IL-1 signaling pathway WP195,0.909269650841762,0.41504479456286686,0.03947639760135966,['TRAF6'],0.9954001499655907,0,0,1
313,Wnt signaling pathway and pluripotency WP399,0.9154555741548028,0.4845317347953128,0.0428003560691571,"['NFYA', 'FZD4']",0.9954001499655907,0,0,2
314,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9171375940977052,0.3996231840944023,0.03456651422156979,['SERPINH1'],0.9954001499655907,0,0,1
315,Endochondral Ossification WP474,0.9171375940977052,0.3996231840944023,0.03456651422156979,['SERPINH1'],0.9954001499655907,0,0,1
316,Integrin-mediated Cell Adhesion WP185,0.9214229653740654,0.4738237633679993,0.038775889997831756,"['PAK1', 'RAC2']",0.9954001499655907,0,0,2
317,Ectoderm Differentiation WP2858,0.923771081774271,0.5212167135743667,0.04132778663463691,"['PODXL', 'FZD4', 'VAX2']",0.9954001499655907,0,0,3
318,Ras signaling WP4223,0.9273874654346682,0.5520402536531569,0.04161490473134554,"['PAK1', 'SYNGAP1', 'RAC2', 'RASGRP1']",0.9954001499655907,0,0,4
319,AGE/RAGE pathway WP2324,0.9276803684735337,0.3785199276638719,0.02841474757550075,['CASP9'],0.9954001499655907,0,0,1
320,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.9308880055203383,0.3719706411854314,0.026639162430232365,['PLCB3'],0.9954001499655907,0,0,1
321,Oncostatin M Signaling Pathway WP2374,0.9308880055203383,0.3719706411854314,0.026639162430232365,['FOS'],0.9954001499655907,0,0,1
322,7q11.23 copy number variation syndrome WP4932,0.9321873356968371,0.45376040637787496,0.03186372754110138,"['VPS37C', 'METTL27']",0.9954001499655907,0,0,2
323,DNA damage response (only ATM dependent) WP710,0.9370313909572787,0.44434924407838367,0.02889980642233852,"['ERBB2', 'RAC2']",0.9954001499655907,0,0,2
324,Wnt signaling WP428,0.9393286041949505,0.4397877113311813,0.02752627317157663,"['PLCB3', 'NOTUM']",0.9954001499655907,0,0,2
325,AMP-activated protein kinase (AMPK) signaling WP1403,0.9396832254384736,0.3536111659753769,0.021999018654483348,['SLC2A4RG'],0.9954001499655907,0,0,1
326,Nonalcoholic fatty liver disease WP4396,0.9412560317512456,0.4893837705918243,0.029627338325369977,"['TRAF2', 'SDHB', 'COX7B2']",0.9954001499655907,0,0,3
327,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9496961230630152,0.33176809803315827,0.01712361851133534,['IFNGR2'],0.9954001499655907,0,0,1
328,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9519283080442361,0.32672102551620624,0.016096092228364785,['CACNG5'],0.9954001499655907,0,0,1
329,Selenium Micronutrient Network WP15,0.9580486088789003,0.3124575597074287,0.013390919378156993,['PTGS2'],0.9954001499655907,0,0,1
330,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9580486088789003,0.3124575597074287,0.013390919378156993,['NOTUM'],0.9954001499655907,0,0,1
331,Ebola Virus Pathway on Host WP4217,0.9598645320884213,0.39513490911774113,0.01618595746770862,"['PAK1', 'VPS33A']",0.9954001499655907,0,0,2
332,IL-18 signaling pathway WP4754,0.9667765923622169,0.5042683196532267,0.017038138261692592,"['TRAF6', 'FOS', 'TRAF1', 'PTPN7', 'PTGS2']",0.9954001499655907,0,0,5
333,Endoderm differentiation WP2853,0.9692626795049483,0.3711287787741518,0.011586499721740657,"['WDHD1', 'HPRT1']",0.9954001499655907,0,0,2
334,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9694714592815472,0.28355527372648487,0.008791416703659544,['CDK7'],0.9954001499655907,0,0,1
335,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9708269736395014,0.2798553521445088,0.008285683163464983,['NOTUM'],0.9954001499655907,0,0,1
336,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9724334994438335,0.5150619946091645,0.014397830205747792,"['CASP9', 'LAMA1', 'CREB3L2', 'TNC', 'FGF1', 'CREB5']",0.9954001499655907,0,0,6
337,Glioblastoma signaling pathways WP2261,0.9745433585715607,0.26931057563587685,0.006944514645592607,['ERBB2'],0.9954001499655907,0,0,1
338,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.97567392204769,0.26596922670104284,0.006549982828776888,['ERBB2'],0.9954001499655907,0,0,1
339,Androgen receptor signaling pathway WP138,0.9777868182627397,0.2595280721278689,0.005829937381869562,['KAT7'],0.9954001499655907,0,0,1
340,Pathways Regulating Hippo Signaling WP4540,0.9797163981633092,0.25339003071107963,0.005192503686976486,['PLCB3'],0.9954001499655907,0,0,1
341,Senescence and Autophagy in Cancer WP615,0.9806174637641706,0.2504280688646057,0.004901588688602601,['CREG1'],0.9954001499655907,0,0,1
342,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9814785467968797,0.24753419809506225,0.0046276822980724835,['SDHB'],0.9954001499655907,0,0,1
343,Circadian rhythm related genes WP3594,0.9845560399846939,0.37685152478511713,0.005865490575006981,"['HOMER1', 'THRAP3', 'NOCT']",0.9954001499655907,0,0,3
344,VEGFA-VEGFR2 Signaling Pathway WP3888,0.9848839257657218,0.5469610962094276,0.008331030616472621,"['DLL4', 'PLCB3', 'PAK1', 'TFCP2', 'GIPC1', 'DHX36', 'CALU', 'NOX4', 'PTGS2', 'HSPA1A']",0.9954001499655907,0,0,10
345,22q11.2 copy number variation syndrome WP4657,0.9876970904782695,0.22420236501561802,0.002775449689633275,['SNAP29'],0.9954001499655907,0,0,1
346,Hippo-Merlin Signaling Dysregulation WP4541,0.990634786222697,0.21093524424495366,0.001984762090993694,['PAK1'],0.9954001499655907,0,0,1
347,Adipogenesis WP236,0.9925398047070688,0.20101590161268126,0.001505239580912053,['EGR2'],0.9954001499655907,0,0,1
348,"GPCRs, Class A Rhodopsin-like WP455",0.997131044451533,0.16781710174029452,0.00048215177235413854,['NPY5R'],0.997131044451533,0,0,1
